Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.
Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer
As per available reports about 43 relevant Journals, 38 Conferences, 30 Workshops are presently dedicated exclusively to drug development and about 1269 articles are being published on drug development.
Drug development can be defined as the process of bringing a new drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research (microorganisms/animals) and clinical trials (on humans) and may include the step of obtaining regulatory approval to market the drug. New chemical entities (NCEs) also known as New Molecular Entities or (NMEs) are compounds which emerge from the process of drug discovery Process of drug development includes Pre-clinical & Clinical studies .
OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide.
Scope and Importance:
Drug Development Conference provides the scope for opportunities to learn progressed by international scientists and academicians. an explosion of genomic information, which is revolutionizing the way drug discovery takes place. Moreover, new fields have arisen such as pharmacogenetics and pharmacogenomics and are touching the goals and guiding principles of drug design and discovery.
Drug development can be defined as the process of bringing a new drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research (microorganisms/animals) and clinical trials (on humans) and may include the step of obtaining regulatory approval to market the drug. New chemical entities (NCEs) also known as New Molecular Entities or (NMEs) are compounds which emerge from the process of drug discovery. These will have promising activity against a particular biological target thought to be important in disease; however, little will be known about the safety, toxicity, pharmacokinetics and metabolism of this NCE in humans. It is the function of drug development to assess all of these parameters prior to human clinical trials. A further major objective of drug development is to make a recommendation of the dose and schedule to be used the first time an NCE is used in a human clinical trial (first-in-man" [FIM] or First Human Dose [FHD]). In addition, drug development is required to establish the physicochemical properties of the NCE: its chemical makeup, stability, solubility.It will be further examined for its suitability to be made into capsules, tablets, aerosol, intramuscular injectable, subcutaneous injectable or intravenous formulations. Together these processes are known in preclinical development as Chemistry, Manufacturing and Control (CMC).Drug development is the process of making a new drug to the market. This can be done after discovering the new compound by drug discovery. Subject new chemicals to a battery of tests designed to detect a particular type of biological activity. Process of drug development can be divided into two types
Chemicals can produce by direct synthesis or isolation from the biological sources. Drug companies continuously analyze thousands of compounds to get therapeutic value. Development of drugs is to promise significant benefit over existing therapy for serious or life-threatening illnesses for which no therapy exists before. There would be so many Challenges has to face during the Development of a Useful Drug. New drugs are developed through a sequence of experiments in a sequence of laboratories and animals and then in patients. If the trial result shows that they would help patients, then the drug becomes part of standard treatment.
The global market for sequencing products and services reached $3.5 billion in 2012. This market is expected to grow to nearly $4.5 billion in 2013 and nearly 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%.
International symposium and workshops
List of Best International Conferences:
This page will be updated regularly.
This page was last updated on August 7, 2020